← Back to patent-cliff list
罗红霉素
Tier C — Watch / tradeRoxithromycin
沈阳红旗制药有限公司
Originator
1986
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：50S ribosomal subunit
Brand：Overall、Rossitrol、Assoral、罗力得、Rulid
Indications (approved)：传染性疾病
Regional status
US
-
EU
-
China
批准上市
1989-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Roxithromycin?
Approved indications include: 传染性疾病.
When does the Roxithromycin patent expire?
No public expiry year is available for Roxithromycin yet; this page updates once verified.
How do I get a quote for Roxithromycin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25